Unichem Laboratories (NSE:UNICHEMLAB) Short-Term Debt: ₹4,297 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:UNICHEMLAB Unichem Laboratories Ltd NSE:UNICHEMLAB
72 GF Score
Price ₹596.95
GF Value ₹679.83
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Unichem Laboratories Short-Term Debt?

Unichem Laboratories NSE:UNICHEMLAB -6.54% 72 Short-Term Debt is ₹4,297 Mil as of Mar. 2026. GuruFocus rates NSE:UNICHEMLAB with a GF Score™ of 72/100 and a GF Value™ of ₹679.83 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Unichem Laboratories's Short-Term Debt for the quarter that ended in Mar. 2026 was ₹4,297 Mil.

Unichem Laboratories's quarterly Short-Term Debt declined from Sep. 2025 (₹4,302 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹4,297 Mil).

Unichem Laboratories's annual Short-Term Debt increased from Mar. 2024 (₹1,809 Mil) to Mar. 2025 (₹3,692 Mil) and increased from Mar. 2025 (₹3,692 Mil) to Mar. 2026 (₹4,297 Mil).

Unichem Laboratories Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Unichem Laboratories Short-Term Debt Related Terms

Unichem Laboratories Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Unichem Laboratories's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Unichem Laboratories Short-Term Debt Chart

Unichem Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,413.52 2,337.44 1,809.30 3,691.60 4,296.60

Unichem Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,691.60 0.00 4,302.20 0.00 4,296.60
NSE:UNICHEMLAB
72GF Score
Unichem Laboratories Ltd NSE:UNICHEMLAB
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of ₹4,297 Mil mean?
Unichem Laboratories (NSE:UNICHEMLAB) has a Short-Term Debt of ₹4,297 Mil as of Mar. 2026.
Is Unichem Laboratories' Short-Term Debt too high?
Unichem Laboratories' current Short-Term Debt is ₹4,297 Mil. Overall, Unichem Laboratories has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Unichem Laboratories' Short-Term Debt compare to ZTS and UTHR?
Unichem Laboratories' Short-Term Debt of ₹4,297 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Drug Manufacturers company?
A good Short-Term Debt depends on the Drug Manufacturers industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Unichem Laboratories's current Short-Term Debt is ₹4,297 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Unichem Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Unichem Laboratories (NSE:UNICHEMLAB) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹679.83, compared to a current price of ₹596.95 — trading 12.2% below its estimated fair value. The current Short-Term Debt is ₹4,297 Mil. Unichem Laboratories' overall GF Score™ is 72/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Unichem Laboratories (NSE:UNICHEMLAB), the current Short-Term Debt is ₹4,297 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Unichem Laboratories (NSE:UNICHEMLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Unichem Laboratories stock appears to be undervalued. The current stock price of ₹596.95 is trading 12.2% below its estimated GF Value™ of ₹679.83. GuruFocus considers Unichem Laboratories to be Modestly Undervalued.

Key valuation signals for NSE:UNICHEMLAB:

  • Short-Term Debt: ₹4,297 Mil
  • GF Value™: ₹679.83 vs. price of ₹596.95 (12.2% below fair value)
  • GF Score™: 72/100 with 6 warning signs

No single metric tells the full story. See the NSE:UNICHEMLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Unichem Laboratories Business Description

Other Exchanges 506690:India
Address Off. S. V. Road, Unichem Bhavan, Prabhat Estate, Jogeshwari (West), Mumbai, MH, IND, 400 102
Unichem Laboratories Ltd is an India based pharmaceutical company. It manufactures a range of Active Pharmaceutical Ingredients (APIs). The company's products are offered in the areas of gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. Some of its products include Apixaban, Brimonidine Tartrate, Finofibrate, Glipizide, Piroxicam and others. The company has a market presence with sales in India and outside India, and the majority of the revenue derived from India. Its product categories comprises Formulations and Bulk Drugs and Chemicals.
72GF Score

Get the complete analysis for NSE:UNICHEMLAB

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹596.95
Price
₹679.83
GF Value